Prostate Cancer - Results from #20440

Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time - Abstract July 25, 2014

A decision model to estimate the cost-effectiveness of intensity modulated radiation therapy (IMRT) compared to three dimensional conformal radiation therapy (3DCRT) in patients receiving radiotherapy to the prostate bed - Abstract July 25, 2014

Multiple repeat prostate biopsies and the detection of clinically insignificant cancer in men with large prostates - Abstract July 25, 2014

Patient opinions on prostate cancer screening are swayed by the United States Preventative Services Task Force recommendations - Abstract July 25, 2014

Drug costs in the management of metastatic castration-resistant prostate cancer in Canada - Abstract July 25, 2014

Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancer - Abstract July 25, 2014

Patient-reported outcome labeling claims and measurement approach for metastatic castration-resistant prostate cancer treatments in the United States and European Union - Abstract July 24, 2014

Prostatectomy pathology findings in an active surveillance population - Abstract July 24, 2014

Prostate cancer outcomes in France: Treatments, adverse effects and two-year mortality - Abstract July 24, 2014

Perceptions of active surveillance and treatment recommendations for low-risk prostate cancer: Results from a national survey of radiation oncologists and urologists - Abstract July 24, 2014

Inefficacy of therapeutic cancer vaccines and proposed improvements. Casus of prostate Cancer - Abstract July 24, 2014

Combined blockade of testicular and locally made androgens in prostate cancer: A highly significant medical progress based upon intracrinology - Abstract July 24, 2014

Criticisms to patient selection in active surveillance in prostate cancer - Abstract July 24, 2014

Economic features of active surveillance - Abstract July 24, 2014

Role of novel risk classification method, Prostate Cancer Risk Index (PRIX) for clinically localized prostate cancer after high-dose-rate interstitial brachytherapy as monotherapy - Abstract July 24, 2014

Depressive symptomatology in men receiving androgen deprivation therapy for prostate cancer: A controlled comparison - Abstract July 24, 2014

Weighted versus unweighted Charlson score to predict long-term other-cause mortality in men with early-stage prostate cancer - Abstract July 23, 2014

Prostate-specific antigen density toward a better cutoff to identify better candidates for active surveillance - Abstract July 23, 2014

Pathology consultation on prostate-specific antigen testing - Abstract July 23, 2014

Clinical utility of endorectal MRI-guided prostate biopsy: Preliminary experience - Abstract July 23, 2014

Page 1023 of 1454